CD276 expression in different tumors and the corresponding normal tissues was investigated on the basis of TCGA and GTEx datasets, and we discovered that CD276 was highly expressed in 30 types of cancer, including ACC, BLCA and BRCA, but expressed at low levels in CESC, LAML and PCPG. The gene discussed is CD276; the disease is bladder transitional cell carcinoma.